Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Carlos, Grande García"'
Autor:
María-Eva Mingot-Castellano, Carlos Grande-García, David Valcárcel-Ferreiras, Clara Conill-Cortés, Loreto de Olivar-Oliver
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Romiplostim, a thrombopoietin-receptor agonist (TPO-ra), is a highly effective option in primary immune thrombocytopenia (ITP), with 80–90% of patients achieving platelet responses after few weeks of treatment. The evidence showing remissions, that
Externí odkaz:
https://doaj.org/article/4dddb6c22ad743c3a567ef280b6c2498
Autor:
Pier Luigi Zinzani, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E. D. Chamuleau, Francesco d’Amore, Corinne Haioun, Catherine Thieblemont, Eva González-Barca, Carlos Grande García, Peter W. Johnson, Gustaaf W. van Imhoff, Thomas Ng, Karen Dwyer, Franck Morschhauser
Publikováno v:
Haematologica, Vol 101, Iss 10 (2016)
Externí odkaz:
https://doaj.org/article/e967f4e7942b405aa20f6c4f091f05e3
Autor:
Zinzani, Pier Luigi, Ansell, Stephen M., Bosch, Francesc, Friedberg, Jonathan W., Marolleau, Jean Pierre, Arcaini, Luca, Garcia-Sanz, Ramon, Gopal, Ajay K., Carlos Grande García, Merryman, Reid, Pinto, Antonio, Smith, Stephen D., Villasboas, Jose Caetano, Wallace, Danielle, Fagerberg, Jan, Magalhaes, Joao, Armand, Philippe
Publikováno v:
Web of Science
TPS7586 Background: EO2463 is a therapeutic vaccine designed to activate existing commensal bacteria-specific memory T cells that cross-react with B cell markers in order to drive anti-tumor immune activity against B-cell malignancies. The four micro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebc90f5ee16174d76037b264862694b9
https://doi.org/10.1200/jco.2022.40.16_suppl.tps7586
https://doi.org/10.1200/jco.2022.40.16_suppl.tps7586
Autor:
Sancho, Juan-Manuel, Marin, Ana, Fernandez, Silvia, Capote, Francisco-Javier, Canigral, Carolina, Carlos Grande García, Donato, Eva, Zeberio, Izaskun, Puerta, Jose-Manuel, Rivas, Alfredo, Perez-Ceballos, Elena, Vale, Ana, Jimenez, Aroa, Loriente, Cristina
Publikováno v:
Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
r-FISABIO. Repositorio Institucional de Producción Científica
Web of Science
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
r-FISABIO. Repositorio Institucional de Producción Científica
Web of Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::406f4629054b9586bcef803c392de46a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3971
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3971
Autor:
Carlos Grande García
Publikováno v:
Annals of Allergy, Asthma & Immunology. 119:298
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d1eca4ecc8cf8671c1032324c73f53
https://doi.org/10.1016/j.anai.2017.07.018
https://doi.org/10.1016/j.anai.2017.07.018
Autor:
Carlos, Grande García, Rafael, Martínez Martínez, David, Valcarcel Ferreiras, Vicente, Vicente-García
Publikováno v:
Medicina clinica. 143(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b521f0a2b8590abbd706b67d37a6900d
https://pubmed.ncbi.nlm.nih.gov/24698715
https://pubmed.ncbi.nlm.nih.gov/24698715
Autor:
Ana Jiménez Ubieto, Andrea Galego, Luis Palomera, Marina Manzanares, Erika Coria, Silvana Novelli, Lucrecia Yáñez, Elena Pérez, Santiago Mercadal, Teresa Palomo, Laura Magnano, Dolores Caballero, Carlos Vallejo, Pilar Martinez Sanchez, Maria J. Rodriguez, Isidro Jarque, Juan José Lahuerta, Carmen Albo, Carlos Grande García, Armando López-Guillermo, Javier Lopez Jimenez, Reyes Arranz, Antonio Salar, Sabela Bobillo, Carmen Marrero, José Javier Ferreiro
Publikováno v:
Blood. 126:521-521
Introduction: At present, determining OS (Overall Survival) remains the gold standard in clinical trial endpoints which evaluate the role of ASCT in FL. However, in the context of a disease characterized by very long median survivals with a continuou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d1588d93ce14e3783cded6c1d1a1b8d
https://doi.org/10.1182/blood.v126.23.521.521
https://doi.org/10.1182/blood.v126.23.521.521
Autor:
Carmen Marrero, S. Bobillo, Erika Coria, Teresa Palomo, Elena Perez, Javier Lopez, Isidro Jarque, Juan José Lahuerta, Lucrecia Yáñez, Maria J. Rodriguez, María Manzanares, José Javier Ferreiro, Carlos Grande García, Andrea Galeo, Laura Magnano, Antonio Salar, Ana Jiménez Ubieto, Santiago Mercadel, Carlos Vallejo, Silvana Novelli, Carmen Albo, Dolores Caballero, Reyes Arranz, Armando López-Guillermo, Luis Palomera
Publikováno v:
Blood. 124:675-675
Background: Patients with high-risk FL intensified with HDT/ASCT may achieve prolonged remissions. The best timing for the procedure remains controversial. Patients who are transplanted in first response show a major Progression Free Survival (PFS) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbfb748ba27cd719e60b78a4326a6bc9
https://doi.org/10.1182/blood.v124.21.675.675
https://doi.org/10.1182/blood.v124.21.675.675
Autor:
Franck Morschhauser, Eva González Barca, Andrew Saunders, Catherine Thieblemont, Karen Dwyer, Francesco d'Amore, Martine E.D. Chamuleau, John Radford, Dolores Caballero, Carlos Grande García, Pier Luigi Zinzani, Bertrand Coiffier, Paul Fields, Corinne Haioun, Gustaaf W. van Imhoff, Peter Johnson
Publikováno v:
Blood. 124:1763-1763
Background CC chemokine receptor 4 (CCR4) is the receptor for macrophage-derived chemokine (MDC/CCL22) and thymus activation-regulated chemokine (TARC/CCL17). CCR4 is expressed on tumour cells in approximately 30-65% of patients with PTCL (Ogura, 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19ed9935ba1d60dd3aae2bde488851a6
https://doi.org/10.1182/blood.v124.21.1763.1763
https://doi.org/10.1182/blood.v124.21.1763.1763
Autor:
Susana Inogés, Fernando Pastor, Luis Palomera, Maurizio Bendandi, Carlos Panizo, Ascensión López Díaz de Cerio, Ricardo García Muñoz, Ana Alfonso, Carlos Grande García, Sara Barea, José Rifón, Mayte Olave
Publikováno v:
Blood. 120:4881-4881
Abstract 4881 Background The current gold standard treatment for follicular lymphoma (FL) consists in the association of rituximab, that is an anti-CD20 monoclonal antibody (mAb), and one among many possible chemotherapy regimens, followed by mainten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e276e7515647c88c6ce2a88d569c2f89
https://doi.org/10.1182/blood.v120.21.4881.4881
https://doi.org/10.1182/blood.v120.21.4881.4881